Eli Lilly announces partnering with Innovent Co., Suzhou, on anticancer antibody drugs, initial payment 56 million USD

The contact comprises at least 3 antibody drugs and can be stepped up to 400 million USD investment upon reaching milestones, the largest US-China pharmaceutical deal ever.

Nikkei Biotech news release, April 20, 2014

Most popular posts: